Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications.

Literature DB >> 16036034

Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications.

Abstract

Various lines of evidence implicate impaired renal function as an important prognostic indicator in patients with congestive heart failure (CHF). Conventional diuretics may aggravate renal dysfunction and can result in neurohumoral activation. Evolving new therapeutic strategies that enhance renal function include administration of B-type natriuretic peptide, adenosine and vasopressin antagonists, and ultrafiltration methods. Prospective studies are needed to evaluate whether these new renal-enhancing strategies will improve patient outcome in CHF.

Entities: Chemical Disease Gene Species

Mesh：

Substances：
Biomarkers
Diuretics

Year: 2004 PMID： 16036034 DOI： 10.1007/s11897-004-0020-9

Source DB: PubMed Journal: Curr Heart Fail Rep ISSN： 1546-9530

43 in total

1. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Authors: Daniel E Forman; Javed Butler; Yongfei Wang; William T Abraham; Christopher M O'Connor; Stephen S Gottlieb; Evan Loh; Barry M Massie; Michael W Rich; Lynne Warner Stevenson; James B Young; Harlan M Krumholz
Journal: J Am Coll Cardiol Date: 2004-01-07 Impact factor: 24.094

2. Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD).

Authors: Adrian F Hernandez; Christopher M O'Connor
Journal: J Am Coll Cardiol Date: 2003-08-20 Impact factor: 24.094

Review 3. Keeping your patient with heart failure safe: a review of potentially dangerous medications.

Authors: Celene M Amabile; Anne P Spencer
Journal: Arch Intern Med Date: 2004-04-12

4. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.

Authors: Stephen S Gottlieb; D Craig Brater; Ignatius Thomas; Edward Havranek; Robert Bourge; Steven Goldman; Farere Dyer; Miguel Gomez; Donald Bennett; Barry Ticho; Evan Beckman; William T Abraham
Journal: Circulation Date: 2002-03-19 Impact factor: 29.690

5. Adenosine formed by 5'-nucleotidase mediates tubuloglomerular feedback.

Authors: S Thomson; D Bao; A Deng; V Vallon
Journal: J Clin Invest Date: 2000-07 Impact factor: 14.808

6. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors: W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

7. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.

Authors: J L Rouleau; M A Pfeffer; D J Stewart; D Isaac; F Sestier; E K Kerut; C B Porter; G Proulx; C Qian; A J Block
Journal: Lancet Date: 2000-08-19 Impact factor: 79.321

8. Usefulness of carperitide for the treatment of refractory heart failure due to severe acute myocardial infarction.

Authors: M Kikuchi; M Nakamura; T Suzuki; M Sato; T Takino; K Hiramori
Journal: Jpn Heart J Date: 2001-05

Review 9. Nonpharmacologic care of heart failure: counseling, dietary restriction, rehabilitation, treatment of sleep apnea, and ultrafiltration.

Authors: Paolo Colonna; Margherita Sorino; Carlo D'Agostino; Francesco Bovenzi; Leonardo De Luca; Francesco Arrigo; Italo de Luca
Journal: Am J Cardiol Date: 2003-05-08 Impact factor: 2.778

10. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

Authors: Michael Domanski; James Norman; Bertram Pitt; Mark Haigney; Stephen Hanlon; Eliot Peyster
Journal: J Am Coll Cardiol Date: 2003-08-20 Impact factor: 24.094

10 in total

Cardiorenal syndrome in decompensated heart failure: prognostic and therapeutic implications.

1. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

2. Sparing a little may save a lot: lessons from the Studies of Left Ventricular Dysfunction (SOLVD).

Review 3. Keeping your patient with heart failure safe: a review of potentially dangerous medications.

4. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.

5. Adenosine formed by 5'-nucleotidase mediates tubuloglomerular feedback.

6. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

7. Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial.

8. Usefulness of carperitide for the treatment of refractory heart failure due to severe acute myocardial infarction.

Review 9. Nonpharmacologic care of heart failure: counseling, dietary restriction, rehabilitation, treatment of sleep apnea, and ultrafiltration.

10. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

Review 1. Cardiorenal syndrome: still not a defined entity.

Review 2. The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

3. Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula.

4. Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.

Review 5. Cardiorenal syndrome: pathophysiology and treatment.

Review 6. The cardiorenal connection in heart failure.

Review 7. Pharmacologic management of the cardiorenal syndrome in heart failure.

8. Heart failure and acute renal dysfunction in the cardiorenal syndrome.

9. Clinical features of cardio-renal syndrome in a cohort of consecutive patients admitted to an internal medicine ward.

Review 10. Natriuretic peptides and therapeutic applications.